RELATED: Zimmer Biomet plots $1B revenue for spine, dental spinoff ZimVie, sets launch date As a standalone company, ZimVie now takes the reins of Zimmer’s longstanding spine and dental businesses.

Zimmer Biomet reported EPS of $2.11 in 4Q, beating analysts’ estimates of $2.06. The company’s 4Q revenues declined by 1.9% year-on-year to $2.09 billion versus analysts’ estimates of $2.08 ...

Biomet Inc., a private equity-backed maker of musculoskeletal medical products, has agreed to acquire Lanx Inc., a venture-backed maker of devices used for spinal surgery.

For all of 2022, ZimVie is expecting to rake in revenues of $1 billion. That’s the same amount the dental and spine businesses registered under the Zimmer Biomet umbrella in 2021, indicating the ...

Zimmer Biomet expects the spin-off to result in an improved financial profile. The Company delivered 2019 and 2020 pro forma revenue totaling $6.96 billion and $6.128 billion, respectively. The ...

(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) announced its intention to spin off the company's Spine and Dental businesses to form a new publicly traded company. The company said, following the ...

ZimVie spin-off was achieved through the distribution of 80.3% of the shares of ZimVie to holders of Zimmer Biomet common stock on 3/1/2022, at one share of ZimVie common stock for every ten ...

(RTTNews) - Musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) announced Friday its intention to spin off its Spine and Dental businesses into a new and independent, publicly traded ...

In other news, the company posted decreased sales in its fourth-quarter and full-year financials (end-December 31, 2020), which it attributed to the COVID-19 pandemic. Its total fourth-quarter sales ...